Abstract
MB Levy, A Elizur, MR Goldberg, L Nachshon, Y Katz. Ann Allergy Asthma Immunol. 2014;112(1):58–63.e1 The goal of this study was to assess the safety and efficacy of milk oral immunotherapy (OIT) in milk-allergic children and adults, including high-risk patients. The study included 280 Israeli patients, ages 4 to 27 years (median age: 7.5 years), with persistent cow’s milk allergy as defined by positive results on skin prick test and/or specific-serum IgE, positive oral food challenge, or history of clinical reaction with accidental exposure in the last 12 months. High-risk patients, including those with a history of anaphylaxis (as defined by involvement of at least …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
